Cell Surface Markers Market is Expected to Reach USD 23.03 Billion Globally in 2019: Transparency Market Research
Summary
Rapid development in healthcare technology, growing preference for reduction of healthcare expenditure by lowering the cost of diagnosis, reduction in the risk of misdiagnosis, rapid and efficient decision making for therapies for specific diseases are some of the major factors which support the growing acceptance of cell surface marker analysis worldwide.Thus in terms of allocations, drug discovery and research segment is expected to dominate the global cell surface markers during the given period of forecast.Improvement in healthcare infrastructure and growing preference for safer and easier targeted therapies are the major factors which will fuel the market growth in these regions.Rapid development in healthcare technology, growing preference for reduction of healthcare expenditure by lowering the cost of diagnosis, reduction in the risk of misdiagnosis, rapid and efficient decision making for therapies for specific diseases are some of the major factors which support the growing acceptance of cell surface marker analysis worldwide.On the other hand, complexity of high-end flow cytometers and high cost of reagents, controls and analysis systems result into lowering the adoption of sophisticated cell marker analysis solutions, particularly in economically lagged countries.It is expected that the global market for flow cytometers will grow at a CAGR of more than 8% from 2013 to 2019 with a cumulative installed base of approximately over 85,000 units by 2019.Disease diagnosis and identification and research and drug discovery are the two prime application areas of cell surface marker analysis.